Dr. Sidonie Golombowski-Daffner

Member of the Supervisory Board since: 2024, elected until 2028

Year of birth: 1964
Nationality: German
Professional qualification: Dr. rer. nat. (neuroscience)

Committees

Member of:

• Nomination Committee
• Innovation Committee

Relevant Knowledge, Skills and Experience

Miss Dr. Sidonie Golombowski-Daffner was CEO and President of Advanced Accelerator Applications SA, a subsidiary of Novartis, from October 2019 to January 1, 2024. During this period she was also a member of the supervisory board of Novartis Germany. Previously, she was General Manager of Novartis Pharma GmbH Nuremberg and Country President Germany since 2017. From 2011 to 2017, Dr. Golombowski-Daffner held management positions at Novartis in Germany and Switzerland. Before that, Dr. Golombowski-Daffner spent 10 years at Sanofi Group companies in various management positions in Germany, France and the Asia-Pacific region. She began her career as a management consultant at Roland Berger, where she advised pharmaceutical customers in the USA, Europe, Russia and Japan for over five years.

Membership of other Supervisory Boards

Membership of Supervisory Boards according to German legal regulations:

• Paul Hartmann AG (listed)

Memberships on similar domestic or foreign control boards of business enterprises:

• none
   

Other significant activities alongside Supervisory Board position:

• none